Antares Therapeutics
Antares Therapeutics is a Boston- and South San Francisco-based precision medicine company developing small-molecule therapies against validated but previously undruggable targets in cancer and other serious diseases. Spun out of Scorpion Therapeutics following Eli Lilly's March 2025 acquisition of
Antares Therapeutics is an API provider whose private shares are listed on 1 secondary market: Forge Global.
Antares Therapeutics publishes 1 API indexed on the APIs.io network.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.